Real concern over an education system that is failing to provide industry with sufficient high calibre scientists to meet its needs has been expressed by the Association of the British Pharmaceutical Industry (ABPI) in its evidence to the House of Commons Science and Technology Committee inquiry into strategic science provision in English universities.
And the evidence supplied by the ABPI is accompanied by a warning that a national strategy for key academic subjects must replace the current situation where local university finance, and funding councils that do not acknowledge industry's requirements, determine the future of education.
As well as employing science graduates in its £9 million-a-day programme of researching and developing new medicines, the pharmaceutical sector is also a significant supporter of academic research. As such, it is well placed to provide expert opinion to the inquiry.
The ABPI's evidence shows that:
A pool of quality science talent should be created, not just to enter industry, but also to sustain academia and to provide the qualified teachers who can encourage pupils to pursue science in higher education.
For further information, please contact: ABPI Press Office 020 7747 1410